3TP-79547-34311
4 vaccinations
16 coded responses
38 check-ins
15 free-text entries
9 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 925 / CA
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-01-15
Survey response — days 1–6 daily, dose 1MedDRA: Asthenia — Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness, NauseaFree text: WeaknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — days 1–6 daily, dose 1MedDRA: Asthenia — Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaFree text: WeaknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Asthenia — Feeling: Good · Site: Pain · NauseaFree text: WeaknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Survey response — days 1–6 daily, dose 1MedDRA: Asthenia — Feeling: Good · NauseaFree text: WeaknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-19
-
2021-01-22
Survey response — day 7, dose 1MedDRA: Asthenia, Emergency care, Medical counselling — Feeling: Fair · Nausea · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Systemic reaction (other): Weakness · Healthcare visit (other): Telehealth lead to ER visit because of generalized weaknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-27
Survey response — day 14, dose 1MedDRA: Condition aggravated, Myasthenia gravis, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Myasthenia gravis is flaring with increased weakness, slurred speech, trouble swallowing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-29
Dose 2 — Pfizer-BioNTech
-
2021-01-29
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · None · Be unable to workAdult check-in
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Increased pulse rate (120s while sitting, 150s while up)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
-
2021-02-12
Survey response — day 14, dose 2MedDRA: Clostridium difficile infection — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: C DiffMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Report sent to call center — day 14, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-19
- 2021-02-26
-
2021-03-05
Survey response — day 35, dose 2MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cough, runny nose, low feverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-12
-
2021-04-15
Call successfulDoes not wish to fill out VAERS report
- 2021-04-30
-
2021-05-13
Call successfulCompleted over the phone
-
2021-05-13
Call successfulCompleted over the phone
-
2021-05-13
Call successfulCompleted over the phone
-
2021-07-30
Survey response — 6 months, dose 2MedDRA: Ovarian cyst, Uterine leiomyoma — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Uterine fibroids and complex ovarian cystMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-30
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-04
-
2021-08-19
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Survey response — day 35, dose 3MedDRA: Oedema peripheral — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Pitting edema in legsMedDRA releases: 2024-11 · check-in free text available
-
2021-09-28
Report sent to call center — day 35, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-09-30
- 2021-09-30
- 2021-10-05
- 2021-10-05
- 2021-11-18
-
2022-02-17
Survey response — 6 months, dose 3MedDRA: Herpes zoster, Stress — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Shingles, but I was under a lot of stress from school, finals, and graduation.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-17
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-21
Call successfulDoes not wish to fill out VAERS report
-
2022-02-21
Call successfulDoes not wish to fill out VAERS report
-
2022-02-21
Call successfulDoes not wish to fill out VAERS report
-
2022-08-21
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID 19MedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Dose 4 — Pfizer-BioNTech
-
2022-10-07
Survey response — days 1–6 daily, dose 4MedDRA: Palpitations — Feeling: Good · Site: Pain, Redness, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection siteFree text: PalpitationsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-08
Health check-in — day 7, dose 4Feeling: Fair · Site: Redness · Headache, Muscle or body aches, Nausea, Abdominal painAdult check-in
- 2022-10-15
-
2022-10-22
Survey response — day 21, dose 4MedDRA: Myasthenia gravis, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Myasthenia gravis exacerbationMedDRA releases: 2024-11 · check-in free text available
-
2022-10-22
Report sent to call center — day 21, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-10-25
Call successfulParticipant prefers to complete VAERS report online
- 2022-10-29
- 2022-11-05
- 2022-11-12
- 2022-12-31
-
2023-04-01
Survey response — 6 months, dose 4MedDRA: COVID-19, Dyspnoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-04-01
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2023-04-04
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech | |
| 3 | 2021-08-19 | Pfizer-BioNTech | No |
| 4 | 2022-10-01 | Pfizer-BioNTech | No |
Call center
9 call center cases
9 successful
VAERS report filed, before or during a call: 3
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Weakness
Systemic reaction (other): Weakness
Systemic reaction (other): Weakness
Systemic reaction (other): Weakness
Release 2 — day 7, dose 1
Systemic reaction (other): Weakness
Healthcare visit (other): Telehealth lead to ER visit because of generalized weakness
Release 2 — day 14, dose 1
Symptoms: Myasthenia gravis is flaring with increased weakness, slurred speech, trouble swallowing.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Increased pulse rate (120s while sitting, 150s while up)
Release 4 — day 14, dose 2
Symptoms: C Diff
Release 5 — day 35, dose 2
Symptoms: Cough, runny nose, low fever
Release 9 — 6 months, dose 2
Symptoms: Uterine fibroids and complex ovarian cyst
Release 9 — day 35, dose 3
Symptoms: Pitting edema in legs
Release 11 — 6 months, dose 3
Symptoms: Shingles, but I was under a lot of stress from school, finals, and graduation.
Release 12 — 12 months, dose 3
Symptoms: COVID 19
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Palpitations
Release 12 — day 21, dose 4
Symptoms: Myasthenia gravis exacerbation
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | ✓ | ✓ | ✓ |
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| SD | Clostridium difficile infection | ✓ | ✓ | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Herpes zoster | · | · | ✓ |
| SD | Myasthenia gravis | ✓ | ✓ | ✓ |
| SD | Oedema peripheral | · | · | ✓ |
| SD | Ovarian cyst | ✓ | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Stress | · | · | ✓ |
| SD | Uterine leiomyoma | ✓ | · | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Palpitations | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release